These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 24770367

  • 21. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
    Marino MG, Bagnato B, Torella I, Franco E.
    Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
    [Abstract] [Full Text] [Related]

  • 22. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
    Lecrenier N, Beukelaers P, Colindres R, Curran D, De Kesel C, De Saegher JP, Didierlaurent AM, Ledent EY, Mols JF, Mrkvan T, Normand-Bayle M, Oostvogels L, Da Silva FT, Vassilev V, Vinals C, Brecx A.
    Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
    [Abstract] [Full Text] [Related]

  • 23. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Harpaz R, Ortega-Sanchez IR, Seward JF, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2008 Jun 06; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
    [Abstract] [Full Text] [Related]

  • 24. Herpes zoster virus vaccine.
    Woolery WA.
    Geriatrics; 2008 Oct 06; 63(10):6-9. PubMed ID: 18828650
    [Abstract] [Full Text] [Related]

  • 25. Herpes zoster subunit vaccine for the prevention of herpes zoster.
    Symoniak MR, Farrokh P, Gandhi MA, Slish JC.
    Am J Health Syst Pharm; 2018 Jun 15; 75(12):861-869. PubMed ID: 29880523
    [Abstract] [Full Text] [Related]

  • 26. Herpes zoster vaccine: A health economic evaluation for Switzerland.
    Blank PR, Ademi Z, Lu X, Szucs TD, Schwenkglenks M.
    Hum Vaccin Immunother; 2017 Jul 03; 13(7):1495-1504. PubMed ID: 28481678
    [Abstract] [Full Text] [Related]

  • 27. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF.
    J Am Acad Dermatol; 2007 Dec 03; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [Abstract] [Full Text] [Related]

  • 28. A novel vaccine (Zostavax) to prevent herpes zoster.
    Holcomb K, Weinberg JM.
    G Ital Dermatol Venereol; 2008 Apr 03; 143(2):119-23. PubMed ID: 18833038
    [Abstract] [Full Text] [Related]

  • 29. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ, Schmader K.
    Herpes; 2007 Sep 03; 14 Suppl 2():45-7. PubMed ID: 17939896
    [Abstract] [Full Text] [Related]

  • 30. Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.
    Oh H, Tan C, Williams C, Giannelos N, Ng C.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2348839. PubMed ID: 38804600
    [Abstract] [Full Text] [Related]

  • 31. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination.
    Chen JY, Chang CY, Lin YS, Hu ML.
    Popul Health Manag; 2012 Dec 31; 15(6):391-7. PubMed ID: 23088666
    [Abstract] [Full Text] [Related]

  • 32. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
    Han R, Gomez JA, de Veras B, Pinto T, Guzman-Holst A, Nieto J, van Oorschot DAM.
    Hum Vaccin Immunother; 2023 Dec 31; 19(1):2164144. PubMed ID: 36821856
    [Abstract] [Full Text] [Related]

  • 33. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF, Lewin B, Hales CM, Sy LS, Harpaz R, Bialek S, Luo Y, Jacobsen SJ, Reddy K, Huang PY, Zhang J, Anand S, Bauer EM, Chang J, Tartof SY.
    J Infect Dis; 2015 Oct 15; 212(8):1222-31. PubMed ID: 26038400
    [Abstract] [Full Text] [Related]

  • 34. Vaccination against herpes zoster in developed countries: state of the evidence.
    Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M.
    Hum Vaccin Immunother; 2013 May 15; 9(5):1177-84. PubMed ID: 23324598
    [Abstract] [Full Text] [Related]

  • 35. Vaccination to prevent herpes zoster in older adults.
    Gnann JW.
    J Pain; 2008 Jan 15; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [Abstract] [Full Text] [Related]

  • 36. Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study.
    Bricout H, Perinetti E, Marchettini P, Ragni P, Zotti CM, Gabutti G, Volpi A, Franco E.
    BMC Infect Dis; 2014 Dec 06; 14():637. PubMed ID: 25479617
    [Abstract] [Full Text] [Related]

  • 37. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.
    Brisson M, Pellissier JM, Camden S, Quach C, De Wals P.
    Hum Vaccin; 2008 Dec 06; 4(3):238-45. PubMed ID: 18382137
    [Abstract] [Full Text] [Related]

  • 38. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Bader MS.
    Postgrad Med; 2013 Sep 06; 125(5):78-91. PubMed ID: 24113666
    [Abstract] [Full Text] [Related]

  • 39. The burden of disease of Herpes Zoster in Tuscany.
    Levi M, Bellini I, Capecchi L, Pieri L, Bechini A, Boccalini S, Callaioli S, Gasparini R, Panatto D, Tiscione E, Bonanni P.
    Hum Vaccin Immunother; 2015 Sep 06; 11(1):185-91. PubMed ID: 25483534
    [Abstract] [Full Text] [Related]

  • 40. Herpes zoster in older adults.
    Cadogan MP.
    J Gerontol Nurs; 2010 Mar 06; 36(3):10-4. PubMed ID: 20302254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.